{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:28:21Z","timestamp":1787308101904,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,21]]},"DOI":"10.7759\/cureus.114912","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:03:53Z","timestamp":1787306633000},"source":"Crossref","is-referenced-by-count":0,"title":["Intravenous Iron Therapy in Heart Failure With Iron Deficiency: An Umbrella Review of Systematic Reviews and Meta-Analyses"],"prefix":"10.7759","author":[{"given":"Abhishek Hanumanpratap Singh","family":"Kshatri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Arif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia","family":"Yousaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minahil","family":"Saif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Muaz","family":"Mushtaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11010125","article-title":"Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology","volume":"11","author":"Alnuwaysir RI","year":"2021","unstructured":"Alnuwaysir RI, Hoes MF, van Veldhuisen DJ, van der Meer P, Grote Beverborg N. Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology. J Clin Med. 2021, 11:10.3390\/jcm11010125","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14310","article-title":"Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis","volume":"10","author":"Salah HM","year":"2023","unstructured":"Salah HM, Savarese G, Rosano GM, Ambrosy AP, Mentz RJ, Fudim M. Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis. ESC Heart Fail. 2023, 10:1473-80. 10.1002\/ehf2.14310","journal-title":"ESC Heart Fail"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh TA","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021, 42:3599-726. 10.1093\/eurheartj\/ehab368","journal-title":"Eur Heart J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric Carboxymaltose in Heart Failure with Iron Deficiency","volume":"389","author":"Mentz RJ","year":"2023","unstructured":"Mentz RJ, Garg J, Rockhold FW, et al.. Ferric Carboxymaltose in Heart Failure with Iron Deficiency. N Engl J Med. 2023, 389:975-86. 10.1056\/NEJMoa2304968","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker SD","year":"2009","unstructured":"Anker SD, Comin Colet J, Filippatos G, et al.. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009, 361:2436-48. 10.1056\/NEJMoa0908355","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-025-03671-1","article-title":"Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency","volume":"31","author":"Anker SD","year":"2025","unstructured":"Anker SD, Karakas M, Mentz RJ, et al.. Systematic review and meta-analysis of intravenous iron therapy for patients with heart failure and iron deficiency. Nat Med. 2025, 31:2640-6. 10.1038\/s41591-025-03671-1","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis","volume":"44","author":"Ponikowski P","year":"2023","unstructured":"Ponikowski P, Mentz RJ, Hernandez AF, et al.. Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis. Eur Heart J. 2023, 44:5077-91. 10.1093\/eurheartj\/ehad586","journal-title":"Eur Heart J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski P","year":"2020","unstructured":"Ponikowski P, Kirwan B-A, Anker SD, et al.. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial. Lancet. 2020, 396:1895-904. 10.1016\/S0140-6736(20)32339-4","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra PR","year":"2022","unstructured":"Kalra PR, Cleland JGF, Petrie MC, et al.. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial. Lancet. 2022, 400:2199-209. 10.1016\/S0140-6736(22)02083-9","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh TA","year":"2023","unstructured":"McDonagh TA, Metra M, Adamo M, et al.. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2023, 44:3627-39. 10.1093\/eurheartj\/ehad195","journal-title":"Eur Heart J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j4008","article-title":"AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both","volume":"358","author":"Shea BJ","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, et al.. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017, 358:j4008. 10.1136\/bmj.j4008","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2013.11.007","article-title":"Systematic review finds overlapping reviews were not mentioned in every other overview","volume":"67","author":"Pieper D","year":"2014","unstructured":"Pieper D, Antoine SL, Mathes T, Neugebauer EA, Eikermann M. Systematic review finds overlapping reviews were not mentioned in every other overview. J Clin Epidemiol. 2014, 67:368-75. 10.1016\/j.jclinepi.2013.11.007","journal-title":"J Clin Epidemiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/eschf\/xvaf018","article-title":"Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"13","author":"Ahmed M","year":"2026","unstructured":"Ahmed M, Zulfiqar E, Hashmi TM, et al.. Intravenous ferric carboxymaltose in patients with heart failure and iron deficiency: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis. ESC Heart Fail. 2026, 13:10.1093\/eschf\/xvaf018","journal-title":"ESC Heart Fail"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2860","article-title":"Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis","volume":"25","author":"Anker SD","year":"2023","unstructured":"Anker SD, Khan MS, Butler J, von Haehling S, Jankowska EA, Ponikowski P, Friede T. Effect of intravenous iron replacement on recurrent heart failure hospitalizations and cardiovascular mortality in patients with heart failure and iron deficiency: A Bayesian meta-analysis. Eur J Heart Fail. 2023, 25:1080-90. 10.1002\/ejhf.2860","journal-title":"Eur J Heart Fail"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinme.2024.100211","article-title":"Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis","volume":"24","author":"Awad AK","year":"2024","unstructured":"Awad AK, Abdelgalil MS, Gonnah AR, et al.. Intravenous iron for acute and chronic heart failure with reduced ejection fraction (HFrEF) patients with iron deficiency: An updated systematic review and meta-analysis. Clin Med (Lond). 2024, 24:100211. 10.1016\/j.clinme.2024.100211","journal-title":"Clin Med (Lond)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2023.06.012","article-title":"Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials","volume":"83","author":"Bhatia K","year":"2024","unstructured":"Bhatia K, Sabharwal B, Gupta K, et al.. Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials. J Cardiol. 2024, 83:105-12. 10.1016\/j.jjcc.2023.06.012","journal-title":"J Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2810","article-title":"Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis","author":"Graham FJ","year":"2023","unstructured":"Graham FJ, Pellicori P, Kalra PR, Ford I, Bruzzese D, Cleland JG. Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis. 2023. 10.1002\/ejhf.2810"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2023.11.006","article-title":"Meta-Analysis and Metaregression of the\u00a0Treatment Effect of Intravenous Iron\u00a0in Iron-Deficient Heart\u00a0Failure","volume":"12","author":"Martens P","year":"2024","unstructured":"Martens P, Augusto SN Jr, Mullens W, Tang WH. Meta-Analysis and Metaregression of the\u00a0Treatment Effect of Intravenous Iron\u00a0in Iron-Deficient Heart\u00a0Failure. JACC Heart Fail. 2024, 12:525-36. 10.1016\/j.jchf.2023.11.006","journal-title":"JACC Heart Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.88989","article-title":"Intravenous Iron Therapy in Patients Admitted With Acute Heart Failure and Iron Deficiency: A Systematic Review and Meta-Analysis","volume":"17","author":"Lopez V","year":"2025","unstructured":"Lopez V, Chac\u00f3n M, Arias MJ, et al.. Intravenous Iron Therapy in Patients Admitted With Acute Heart Failure and Iron Deficiency: A Systematic Review and Meta-Analysis. Cureus. 2025, 17:e88989. 10.7759\/cureus.88989","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/08998280.2024.2326387","article-title":"Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"37","author":"Mhanna M","year":"2024","unstructured":"Mhanna M, Sauer MC, Al-Abdouh A, et al.. Intravenous iron therapy for patients with iron deficiency and heart failure: a systematic review and meta-analysis of randomized controlled trials. Proc (Bayl Univ Med Cent). 2024, 37:466-76. 10.1080\/08998280.2024.2326387","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.hsr.2023.100131","article-title":"Intravenous iron therapy for iron deficiency in patients with heart failure: An updated systematic review and meta-analysis","volume":"9","author":"Oli PR","year":"2023","unstructured":"Oli PR, Shrestha DB, Shikhrakar S, et al.. Intravenous iron therapy for iron deficiency in patients with heart failure: An updated systematic review and meta-analysis. Health Sci Rev. 2023, 9:100131. 10.1016\/j.hsr.2023.100131","journal-title":"Health Sci Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1080\/20565623.2024.2367956","article-title":"Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis","volume":"10","author":"Rangwala BS","year":"2024","unstructured":"Rangwala BS, Zuhair V, Mustafa MS, et al.. Ferric carboxymaltose for iron deficiency in patients with heart failure: a systematic review and meta-analysis. Future Sci OA. 2024, 10:2367956. 10.1080\/20565623.2024.2367956","journal-title":"Future Sci OA"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2025.178314","article-title":"Intravenous ferric carboxymaltose for iron deficiency in heart failure patients: A meta-analysis with trial sequential analysis","volume":"1008","author":"Shalabi L","year":"2025","unstructured":"Shalabi L, Ibrahim A, Ramadan S, et al.. Intravenous ferric carboxymaltose for iron deficiency in heart failure patients: A meta-analysis with trial sequential analysis. Eur J Pharmacol. 2025, 1008:178314. 10.1016\/j.ejphar.2025.178314","journal-title":"Eur J Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40261-024-01401-y","article-title":"Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients","volume":"44","author":"Taha AM","year":"2024","unstructured":"Taha AM, Elsaeidy AS, Nada SA, et al.. Efficacy of Intravenous Ferric Carboxymaltose in Heart Failure Patients with Iron Deficiency Anemia: A Meta-analysis of 6271 Patients. Clin Drug Investig. 2024, 44:879-96. 10.1007\/s40261-024-01401-y","journal-title":"Clin Drug Investig"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020","volume":"36","author":"Ponikowski P","year":"2015","unstructured":"Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al.. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency\u2020. Eur Heart J. 2015, 36:657-68. 10.1093\/eurheartj\/ehu385","journal-title":"Eur Heart J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.054271","article-title":"Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency","volume":"144","author":"Sawicki KT","year":"2021","unstructured":"Sawicki KT, Ardehali H. Intravenous Iron Therapy in Heart Failure With Reduced Ejection Fraction: Tackling the Deficiency. Circulation. 2021, 144:253-5. 10.1161\/CIRCULATIONAHA.121.054271","journal-title":"Circulation"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/516925-intravenous-iron-therapy-in-heart-failure-with-iron-deficiency-an-umbrella-review-of-systematic-reviews-and-meta-analyses","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T10:03:54Z","timestamp":1787306634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/516925-intravenous-iron-therapy-in-heart-failure-with-iron-deficiency-an-umbrella-review-of-systematic-reviews-and-meta-analyses"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.114912","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}